High court asked to take case that could determine size of eye drops
What most people see as an annoyance, some prescription drop users say is grounds for a lawsuit.
Pharmaceutical
Articles
Former Lilly CFO Rice to lead CVS Caremark, report says
Derica Rice, 53, one of the nation’s most powerful black executives, retired from Indianapolis-based drugmaker Eli Lilly and Co. in December, after the company passed him over when naming a new CEO.
House rejects GOP bill easing use of unproven drugs
The House rejected legislation Tuesday that would ease how experimental drugs are provided to people with terminal illnesses.
‘Rigged’ system blocks lower-cost drugs, head of FDA says
FDA Commissioner Scott Gottlieb aimed particular criticism at giant pharmacy benefit managers that contract with health plans to administer coverage of drugs, saying the industry’s tactics have stymied cheaper copies of expensive biotechnology drugs.
FDA opens new path for Alzheimer’s therapy as failures mount
The Food and Drug Administration proposal will create new opportunities for drugmakers after repeated failures from companies including Indianapolis-based Eli Lilly and Co.
Hot-selling Lilly anti-inflammatory drug passes key hurdle for third use
The Indianapolis-based drugmaker said the medicine, called Taltz, proved effective for treating a type of back stiffness, and hopes to submit it for government approval this year.
Report: Opioid makers gave $10M to advocacy groups amid epidemic
Companies selling some of the most lucrative prescription painkillers funneled millions of dollars to advocacy groups that in turn promoted the medications' use, according to a report released Monday
Trump’s big promises on drug costs followed by modest steps
As a candidate, President Trump advocated Medicare negotiations and allowing consumers to import medicines from abroad. His current strategy recommends changes to policies that the administration believes unwittingly lead to higher prices, and suggests ways to speed drugs to market and increase competition.
Secret discounts keep drug bills from soaring, middlemen say
Express Scripts Holding Co., one of the biggest pharmacy-benefits managers, says the drug-price deals it cuts behind closed doors are saving consumers a lot of money.
Hospital groups creating company to make cheap generic drugs
Several major not-for-profit hospital groups, including the parent of St. Vincent Health in Indianapolis, are trying their own solution to drug shortages and high prices.
Lilly looks to boost pipeline with drug partnerships
A slimmed-down Eli Lilly and Co., thousands of employees lighter after its biggest restructuring in nearly a decade, is now looking high and low for deals to bulk up its drug pipeline.
Trump health pick wary of government drug price negotiations
Alex Azar, a former Eli Lilly and Co. executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he'd work to lower them if confirmed as secretary of Health and Human Services.
Nearly a dozen Indiana communities sue opioid industry in new flurry of suits
A wide array of cities, towns and counties are blaming opioid makers and distributors for flooding their communities with addictive painkillers.
Pfizer to end Alzheimer’s research, cut 300 jobs
Pfizer said it will continue its support of potential blockbuster drug tanezumab, a late-stage pain treatment in development with Indianapolis-based Eli Lilly and Co.
Assembly Biosciences’ market value surges to nearly $1B, despite red ink
The 5-year-old Carmel biotech has won plenty of attention from Wall Street and has secured more than $100 million through licensing deals and a stock offering to help fund expensive clinical trials.
Is marijuana debate at a tipping point?
A fight over whether Indiana should legalize medical marijuana seems all but inevitable now.
Hot-selling Lilly drug gets OK for second use
Taltz, launched in 2016 to treat plaque psoriasis, won approval from the Food and Drug Administration for a second indication—treating adults with a form of arthritis.
FDA aims to expand early-approval program for promising drugs
The Food and Drug Administration wants to help patients get faster access to promising cancer treatments, FDA Commissioner Scott Gottlieb told House lawmakers Thursday.
Tangled incentives push drugmakers away from opioid solutions
Pharmaceutical companies have introduced medicines to treat dependence, reverse overdoses and deal with opioid side effects. But few effective and economically viable alternatives to addictive painkillers have emerged from the laboratory.
Former Pharmakon exec pleads guilty to 10 criminal charges
Caprice Bearden, 63, of Carmel pleaded guilty in U.S. District Court to one count of conspiracy to defraud the United States and nine misdemeanor counts related to the sale of adulterated drugs, including painkillers that were used on hospitalized infants.